Semaglutide(Daewon Pharmaceutical)
司美格鲁肽（韩国大元制药株式会社）
Report date: 2023/08/10 14:44:58
Base Information
Drug NameSemaglutide(Daewon Pharmaceutical)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesDaewon Pharmaceutical Co LtdRaphas Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesRaphas Co LtdDaewon Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A